Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 14.064% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) O=C(COC(=O)/C=C/c1cccc(C(F)(F)F)c1)NCc1ccc(F)cc1
(b) Cn1cc(C(=O)NCc2cccnc2)c(=O)c2cc(S(=O)(=O)N3CCCCCC3)ccc21
Answer: b. Cn1cc(C(=O)NCc2cccnc2)c(=O)c2cc(S(=O)(=O)N3CCCCCC3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1cc(C(=O)NCc2cccnc2)c(=O)c2cc(S(=O)(=O)N3CCCCCC3)ccc21
Cn1cc(C(=O)NCc2cccnc2)c(=O)c2cc(S(=O)(=O)N3CCCCCC3)ccc21
6-(azepan-1-ylsulfonyl)-1-methyl-4-oxo-N-(pyridin-3-ylmethyl)quinoline-3-carboxamide